AxoGen, Inc. Reports 2018 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
UPDATE: AxoGen (AXGN) Reports In-Line Q1 EPS
April 30, 2018 4:09 PM EDT(Updated - April 30, 2018 5:43 PM EDT)
(Updates shows adjusted EPS)
AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $17.08 million.
Management reiterates 2018 revenue... More
